Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.

European Crypto Asset Manager CoinShares Starts US Hedge Fund DivisionWall Street Selloff Across Assets Rattles Risk-Parity QuantsBlackRock, State Street Among Money Managers Closing ESG FundsCathie Wood Sees Revival of Thematic Investing When Fed Cuts RatesCathie Wood’s Ark Buys Rize ETF in Big Bet on European GrowthJanus Henderson Is Dominating the CLO ETF MarketAirline Stocks Tumble Into Bear Market on Soaring Oil PricesCathie Wood, Boaz Weinstein Among Winners From Bitcoin Fund BetZero-Day...

4 Trillion ETF MarketFund Managers See Water Risk in Semiconductor Bets Being MispricedPlaying for global basketball and sponsorship gloryFanDuel, Rivalry deliver something new for betting customersWomen’s Tennis Is More Unpredictable — And Fun — Than Ever Going Into US OpenDifficult conversations regarding hockey's 'toxic masculinity' continue at summitMLB makes strides in attracting younger fans, ticket buyers in growing the gameRoyals unveil proposed ballpark, entertainment...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in CA
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Canada Canada Latest News, Canada Canada Headlines